Investor Presentation and Update
Brisbane, July 11, 2016 AEST (ABN Newswire) - Anatara Lifesciences (
ASX:ANR) releases its latest institutional roadshow presentation and market update. This week CEO & Chairman Dr Mel Bridges and Co-Founder and Chief Scientific Officer (CSO) Dr Tracey Mynott will be conducting a roadshow updating existing and potential new institutional investors and analysts.
Key points:
- On track to lodge for regulatory approval for Detach(TM) in Australia
- Expanded executive team on board
- Targeting livestock focus past just pigs, to cattle & poultry
- Looking to attract new institutional interest
- Increasing focus on key human applications
- Strong balance sheet
Dr Bridges said, "As Anatara continues to deliver on its milestones and builds its share price to more than two times its issue price less than two years ago, the company is starting to attract new institutional and high net-worth interest in the company."
"We are also looking to expand analyst research coverage on ANR. This week's roadshow is about building our brand awareness as the company increases its focus on gastrointestinal (gut) opportunities for its core therapeutic compounds in the human area as well as expanding applications in replacing antibiotics in the livestock area," Dr Bridges added.
The new executive team appointments will allow the Anatara team more time to focus on moving the animal health initiatives to completion, as the Company increases its over-the-counter (OTC) opportunities in the human area.
"With a strong balance sheet, we are set to move Anatara significantly forward on all fronts. We have completed our forward 3 year plan projections and remain committed to continuing to execute on our key milestones," Dr Bridges added.
To view the presentation, please visit:
http://abnnewswire.net/lnk/FGUO2UQ3
About Anatara Lifesciences Limited
Anatara Lifesciences Limited (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing productsfor human and animal health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders.
| ||
|
